Profiles

  • Three Biotech Game Changers
    Three pioneers describe the building of biotech in India, Brazil and China. by Richard Gallagher
  • Charting Her Own Course
    An Indian CEO embraces research alongside the development of generics and biosimilars by Richard Gallagher
  • Building the Critical Mass
    A Brazilian CEO turned venture capitalist makes multiple contributions to the biotech field by Richard Gallagher
  • The Elements of Service
    A Chinese CEO develops end-to-end contract research and manufacturing capabilities by Richard Gallagher
  • A Q&A close-up
    To gain deeper insight into the personalities of biotech pioneers Kiran Mazumdar-Shaw, Guilherme Emrich, Ge Li, & Richard Gallagher posed some broad questions. Here are their replies. by Richard Gallagher , Kiran Mazumdar-Shaw , Guilherme Emrich and Ge Li
  • Timeline
    Here, the milestones in the careers of Ge Li, Guilherme Emrich and Kiran Mazumdar-Shaw are set against landmark economic developments in their countries. by Richard Gallagher
  • 2: Intensity
    Measuring a country's biotech "blood pressure" demands multiple approaches
  • 3: Enterprise Support
    Biotechnology thrives only when a country maintains a broad collection of business resources
Worldview Scorecard
MORE
Honduras Saudi Arabia
Hungary Switzerland
Ireland Uganda
Italy U.S.
Japan Vietnam
Country Spotlights
MORE
Perspectives
MORE
Advertisement
Profiles
MORE